<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Localized intravascular coagulation (prethrombi, fibrin <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e>, aggregation and agglutination of red blood cells) in the microcirculatory bed of the brain in hemorrhagic <z:hpo ids='HP_0001297'>stroke</z:hpo> is secondary to <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Microcirculatory impairments, as well as consumption of coagulation factors and fibrinolysis activation aggravate cerebral circulation disorders and contribute to an expansion of the involved area </plain></SENT>
<SENT sid="2" pm="."><plain>Identification of the causes of the development, place and role of intravascular coagulation in the patho- and thanatogenesis of hemorrhagic <z:hpo ids='HP_0001297'>strokes</z:hpo> will make it possible to determine the ways of adequate medicated correction of these <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">hemostatic disorders</z:e> </plain></SENT>
</text></document>